CRSP

39.0400.28%
JR

James R. Kasinger

General Counsel & Secretary

Mr. James R. Kasinger, J.D., serves as General Counsel & Secretary of CRISPR Therapeutics, Inc. since May 2017. Mr. Kasinger has been General Counsel and Secretary at CRISPR Therapeutics AG since May 2017. He served as Secretary of Moderna, Inc. until May 2017. Mr. Kasinger is a highly accomplished lawyer with years of legal experience in various settings. He joins CRISPR Therapeutics to oversee corporate legal and governance matters. Prior to joining CRISPR Therapeutics, Mr. Kasinger held the role of General Counsel and Secretary at Moderna Therapeutics, a Cambridge-based biotechnology company and as General Counsel at PlumChoice, Inc. Prior to these roles, Mr. Kasinger was a partner at the global law firm, Goodwin Procter LLP, where he represented life sciences, technology and other high-growth companies in all stages of their life cycles, from formation, to obtaining seed and growth financings, to initial public offering, merger or sale. Mr. Kasinger started his legal career at Testa, Hurwitz & Thibeault. Mr. Kasinger holds a J.D. from Boston College Law School, graduating cum laude and a B.A. from Wheaton College, graduating magna cum laude.

Positions